News for Xeris Pharmaceuticals, Inc. (XERS)

PR NewswireCHICAGO and ARLINGTON, Va., Jan. 21, 2025 Strategic collaboration formed to raise awareness that all people with diabetes on blood glucose-lower

Earnings call: Xeris Biopharma sees 26% revenue surge in Q2 2024

Xeris Pharmaceuticals (XERS) Q2 earnings results to be announced on August 8th.

Xeris Pharmaceuticals is set to announce Q1 earnings on May 9th.

Operator: Hello everyone and welcome to the Xeris fourth quarter and full year 2023 financial results conference call and webcast. My name is Emily and I’ll be coordinating your call today.

Earnings call: Xeris Biopharma reports robust growth and strategic refinancing

Xeris Pharmaceuticals reports Q4 2023 financial results, beating revenue expectations.

Xeris Pharmaceuticals is set to announce Q4 earnings results, with expectations of a -$0.09 EPS and $43.55M revenue, based on upward revisions.

Operator: Hello, everyone and welcome to the Xeris Biopharma Third Quarter 2023 Financial Results Call. My name is Bruno. I'll be operating your call today.

According to the report by Fortune Business Insights, the global autoinjectors market size is projected to reach USD 233.69 billion by 2030, at a CAGR of...

Updated guidelines recognize the benefits of ready-to-use glucagon Protecting all people with diabetes at risk of severe hypoglycemia remains the goal ...

(RTTNews) - Xeris Biopharma Holdings Inc. (XERS) said Monday that the U.S. Food and Drug Administration granted its subsidiary Xeris Pharmaceutica...

/PRNewswire/ -- Global Bio-Pharma Market is valued at USD 274.10 Billion in 2020 and is expected to reach USD 703.28 Billion by 2027 with a CAGR of 12.5% over...

Read Research Analysts’ Upgrades for May 19th (AAVMY, AAWW, AIT, AMOT, AMRN, AMZN, ATO, BCH, BCS, BECN) at ETF Daily News

Read Xeris Biopharma (NASDAQ:XERS) Upgraded at Zacks Investment Research at ETF Daily News

PDS Biotechnology Appoints Seasoned Business Development Executive Sanjay Zaveri as Senior Vice President, Business Development - read this article along with other careers information, tips and advice on BioSpace

Reports An Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)...

FLORHAM PARK, N.J., May 18, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (NASDAQ:PDSB), a clinical-stage immunotherapy company developing a growing pipeline of molecularly targeted cancer immunotherapies and

Read 50,169 Shares in Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) Acquired by Ieq Capital LLC at ETF Daily News